How much does Miltenyi Biotec Limited make?

Miltenyi Biotec Limited reported revenue of £46m and £2.4m profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Miltenyi Biotec Limited have?

Miltenyi Biotec Limited reported an average of 57 employees in the year to 31 Dec 2025.

Is Miltenyi Biotec Limited profitable?

Yes — Miltenyi Biotec Limited reported a profit of £2.4m in the year to 31 Dec 2025.

Company No. 03096272 · Incorporated 30 Aug 1995

Miltenyi Biotec Limited

Registered name: MILTENYI BIOTEC LIMITED

Part of Miltenyi Biotec B.V. & Co. Kg group

Miltenyi Biotec Limited made £46m revenue and £2.4m profit in the year to 31 Dec 2025.

Miltenyi Biotec Limited’s revenue grew 31% to £46m in the year to 31 Dec 2025, with £2.4m profit and 57 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Woking; we hold 4 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 21100Manufacture of basic pharmaceutical products SIC 86900Other human health activities

Status: Active
Location: Woking, South East
Age: 31 yrs · since 1995
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Capital-lightCash flow filed

Revenue

£46m

Growth ▲31%

Profit

£2.4m

Growth ▲2.5%

Profit margin

5.3%

Gross 20.9%

Employees

Change 0%

Profit / employee

£42.6k

Revenue/employee £808k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£34.2m	£29.2m	£35.2m	£46m
Cost of sales	£26m	£21m	£26m	£36.4m
Gross profit	£8.2m	£8.1m	£9.2m	£9.6m
Operating profit	£2.1m	£1.2m	£3.1m	£3.2m
Profit before tax	£2.1m	£1.2m	£3.2m	£3.3m
Profit after tax	£1.6m	£970k	£2.4m	£2.4m
Profit (best available)	£1.6m	£970k	£2.4m	£2.4m
Staff costs	£4.3m	£5m	£4.8m	£5.3m
Employees (average)	60	67	57	57
Ratios
Profit margin	4.8%	3.3%	6.7%	5.3%
Gross margin	24%	27.8%	26%	20.9%
Revenue per employee	£570k	£435k	£617k	£808k
Profit per employee	£27.5k	£14.5k	£41.6k	£42.6k
Cash conversion	−30.5%	−303.3%	−139.1%	−87.7%
Growth (year on year)
Revenue growth	—	▼14.7%	▲20.6%	▲31%
Profit growth	—	▼41.2%	▲144.2%	▲2.5%
Headcount growth	—	▲11.7%	▼14.9%	0%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.9m	£2.5m	£3.5m	£4.7m
Net assets	£3.2m	£2.1m	£1.4m	£3.9m
Fixed assets	£1.5m	£1.8m	£1.3m	£1.5m
Current assets	£8.9m	£7.4m	£10m	£12.1m
Debtors	£4.5m	£2.3m	£3.7m	£4m
Deferred income	£3.3m	£3.6m	£3.7m	£4.5m
Cash from operations	−£651k	−£3.6m	−£4.3m	−£2.8m
Source	Accounts · bulk data Sep 2024	Accounts · bulk data Sep 2024	FullAccounts · bulk data Jul 2025	FullAccounts · bulk data Aug 2026

Derived from the latest filing

How the business works

Profit margin: 5.3%; Profit ÷ revenue.
Gross margin: 20.9%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £808k; Revenue ÷ average employees.
Profit per employee: £42.6k; Profit ÷ average employees.
Cash conversion: −87.7%; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 3.2%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 9.7%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 8.7%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲167%; Now £3.9m
Cash at bank: ▲35%; Now £4.7m
Headcount: 0%; Now 57
Deferred income: ▲20%; Now £4.5m
Fixed assets: ▲11%; Now £1.5m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Miltenyi Biotec B.V. & Co. Kg (registered outside the UK register)ultimate parent75–100%
Miltenyi Biotec Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £2.4m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.